Your browser doesn't support javascript.
loading
Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
Pu, Xiaohui; Li, Jia; Qiao, Peng; Li, Mengmeng; Wang, Haiyan; Zong, Lanlan; Yuan, Qi; Duan, Shaofeng.
Afiliação
  • Pu X; Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, China.
  • Li J; Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, China.
  • Qiao P; Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, China.
  • Li M; Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, China.
  • Wang H; Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, China.
  • Zong L; Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, China.
  • Yuan Q; National & Local Joint Engineering Research Center for Applied Technology of Hybrid Nanomaterials, Henan University, Jinming Road, Kaifeng, 475004, China.
  • Duan S; Institute of Materia Medica, School of Pharmacy, Henan University, Jinming Road, Kaifeng, 475004, China.
Curr Cancer Drug Targets ; 19(4): 285-295, 2019.
Article em En | MEDLINE | ID: mdl-30520373

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Sistemas de Liberação de Medicamentos / Dióxido de Silício / Nanoestruturas / Nanomedicina / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Curr Cancer Drug Targets Assunto da revista: ANTINEOPLASICOS / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Sistemas de Liberação de Medicamentos / Dióxido de Silício / Nanoestruturas / Nanomedicina / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Curr Cancer Drug Targets Assunto da revista: ANTINEOPLASICOS / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China